Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank86
3Y CAGR+30.5%
5Y CAGR-26.1%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+30.5%/yr
Annual compound
5Y CAGR
-26.1%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.25 | +344.0% |
| 2024 | 0.73 | -32.6% |
| 2023 | 1.09 | -25.8% |
| 2022 | 1.46 | -29.4% |
| 2021 | 2.07 | -85.9% |
| 2020 | 14.74 | +185.8% |
| 2019 | -17.18 | -844.2% |
| 2018 | -1.82 | - |